Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib - Coombes, RC; Howell, S; Lord, SR; Kenny, L; Mansi, J; Mitri, Z; Palmieri, C; Chap, LI; Richards, P; Gradishar, W; Sardesai, S; Melear, J; et al. (Nature Communications, 2023)